Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-28 Other | 2020-01-30 5:15 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | G1 EXECUTION SERVICES LLC SUSQUEHANNA FUNDAMENTAL INVESTMENTS LLC SUSQUEHANNA SECURITIES LLC 10% Owner | 14,126,415 | $6.3 | 14,126,415 (Direct) | View |
Ownership | 2020-01-30 5:07 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | G1 EXECUTION SERVICES LLC SUSQUEHANNA FUNDAMENTAL INVESTMENTS LLC SUSQUEHANNA SECURITIES LLC 10% Owner | 0 | $0 | 14,612,415 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 5:30 pm | N/A 2020-12-16 | ACHILLION PHARMACEUTICALS INC | ACHN | VITULLO NICOLE Director | 272,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 5:30 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | VITULLO NICOLE Director | 3,454,972 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:17 pm | N/A 2028-08-20 | ACHILLION PHARMACEUTICALS INC | ACHN | Zelenkofske Steven EVP, Chief Medical Officer | 700,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:16 pm | N/A 2026-01-25 | ACHILLION PHARMACEUTICALS INC | ACHN | Verwiel Frank Director | 132,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:16 pm | N/A 2021-12-12 | ACHILLION PHARMACEUTICALS INC | ACHN | VAN NOSTRAND ROBERT L Director | 227,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:16 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | VAN NOSTRAND ROBERT L Director | 40,000 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A 2026-01-20 | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph Chief Executive Officer | 2,892,766 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph Chief Executive Officer | 3,500 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A 2021-12-12 | ACHILLION PHARMACEUTICALS INC | ACHN | Scheer David Director | 227,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | Scheer David Director | 92,764 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A 2028-02-09 | ACHILLION PHARMACEUTICALS INC | ACHN | MANNING MARTHA E General Counsel | 610,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | MANNING MARTHA E General Counsel | 2,500 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:14 pm | N/A 2026-01-25 | ACHILLION PHARMACEUTICALS INC | ACHN | KISHBAUCH MICHAEL D Director | 163,250 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:14 pm | N/A 2026-01-25 | ACHILLION PHARMACEUTICALS INC | ACHN | Graves Kurt Director | 292,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:14 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | Graves Kurt Director | 22,709 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:13 pm | N/A 2028-08-15 | ACHILLION PHARMACEUTICALS INC | ACHN | Gibney Anthony S EVP, Chief Business Officer | 700,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:13 pm | N/A 2021-12-12 | ACHILLION PHARMACEUTICALS INC | ACHN | FISHERMAN JASON S Director | 227,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:13 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | FISHERMAN JASON S Director | 91,500 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:13 pm | N/A 2028-09-11 | ACHILLION PHARMACEUTICALS INC | ACHN | Firuta Paul E EVP, Chief Commercial Officer | 600,000 | $0 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:12 pm | N/A 2028-08-07 | ACHILLION PHARMACEUTICALS INC | ACHN | Di Donato Brian SVP, Chief Financial Officer | 700,000 | $0 | 0 (Direct) | View |